RxDoctor Payments Data

Brent Walker, MD

Interventional Pain Medicine · Little Rock, ARNPI 1952398687

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,261 of the $4,303 with a category attached, or 75.8%. 8 manufacturers reported payments, led by Abbott at 59.8% of the total. Reporting peaked in 2023 at $2,383 and has fallen 89.7% since, to $245 in 2025.

$4,303in general payments, 2019–2025

Across 35 payments — averaging $122.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Pacira Pharmaceuticals Incorporated$789
  • Medtronic$757
  • Flowonix Medical Incorporated$58
  • Vertos Medical, Inc.$57
  • Boston Scientific$40
  • plus $31 from 2 others

What the payments were for

  • Travel & lodging$3,26176%
  • Food & beverage$98423%
  • Entertainment$581%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,303 in reported general payments places this provider in the 55th percentile of 29 interventional pain medicine providers in Arkansas.

See all interventional pain medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$355,250
Medicare patients
782
Services billed
4,387

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen378$9,757
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen401$8,861
OxycontinOxycodone Hcl12$5,202
Buprenorphine24$5,046
Clonidine64$4,006
Gabapentin263$2,899
Pregabalin66$2,203
Oxycodone Hcl143$1,871
Tizanidine Hcl204$1,797
Amitriptyline Hcl96$918
Cyclobenzaprine Hcl62$722
Diclofenac Sodium40$558
Tramadol Hcl135$418
Duloxetine Hcl41$366
Methadone Hcl23$326

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →